Skip to Content Skip to Footer
Andrew S. Pumerantz, DO, MPH

Andrew S. Pumerantz, DO, MPH

Professor and Director, Department of Population Health Science Co-Director, DO-MPH Dual Enrollment ProgramAdjunct Professor, School of Community and Global Health, Claremont Graduate University

College of Osteopathic Medicine of the Pacific

apumerantz@westernu.edu

Phone: 909-469-5227 | Fax: 909-469-5660

Join year: 2007

  • Education

    Education and Postdoctoral Training:

    2019-2021 Master of Public Health, University of California, Berkeley, School of Public Health, Berkeley, CA

    2012 Value-Based Health Care Delivery Intensive Seminar, Harvard Business School, Boston, MA

    2010 Management Development Program, Harvard Graduate School of Education, Harvard Institutes of Higher Education, Cambridge, MA

    1993-1995 Fellow in Infectious Diseases, Yale University School of Medicine, New Haven, CT

    1992-1993 Chief Medical Resident, Mount Sinai Beth Israel, Mount Sinai School of Medicine, New York, NY

    1989-1992 Resident in Internal Medicine, Mount Sinai Beth Israel, Mount Sinai School of Medicine, New York, NY

    1988-1989 Rotating Intern, Metropolitan Hospital, Springfield, PA

    1984-1988 Doctor of Osteopathic Medicine, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

    1980-1984 Bachelor of Arts, Biology, Occidental College, Los Angeles, CA

  • Certification

    2012-2022 Internal Medicine, American Board of Internal Medicine

    2006-2016 Infectious Disease, American Board of Internal Medicine

    2002-2012 Internal Medicine, American Board of Internal Medicine

    2005 Certificate in Travel Health, International Society of Travel Medicine

    1996-2006 Infectious Disease, American Board of Internal Medicine

    1992-2002 Internal Medicine, American Board of Internal Medicine

  • License

    2006 California

    1992 Connecticut

    1989 New York State

    1989 National Board of Osteopathic Medical Examiners

  • Professional Experience

    Academic Appointments:

    2021- Co-Director, DO-MPH Dual Enrollment Program; Adjunct Professor, School of Community and Global Health, Claremont Graduate University, Claremont, CA

    2018- Professor and Director, Department of Population Health, College of Osteopathic Medicine of the Pacific (California) & COMP-NW (Oregon), Western University of Health of Sciences (WesternU)

    2015- Professor of Internal Medicine, WesternU/COMP, Pomona, CA

    2015- Visiting Clinical Professor of Global Health, Jodhpur School of Public Health, Jodhpur, Rajasthan, India

    2012-2018 Assistant Provost for Strategic Initiatives, WesternU

    2009-2018 Founder and Executive Director, Western Diabetes Institute at WesternU

    2007-2016 Chief, Division of Infectious Disease, WesternU/COMP, Pomona, CA

    2008-2012 Chair, Department of Internal Medicine, WesternU/COMP, Pomona, CA

    2007-2015 Associate Professor of Internal Medicine, WesternU/COMP, Pomona, CA

    1995-1999 Instructor, Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT

    1992-1993 Associate in Medicine, Mount Sinai School of Medicine, New York, NY

    Hospital Appointments:

    2010-2012 Consultant, Pomona Valley Hospital Medical Center, Pomona, CA

    2007-2011 Consultant, Arrowhead Regional Medical Center, Colton, CA

    2001-2007 Consultant, Long Island Jewish Medical Center, New Hyde Park, NY

    1999-2007 Assistant Attending/Consultant, North Shore University Hospital, Manhasset, NY

    1999-2007 Consultant, St. Francis Hospital, Roslyn, NY

    1999-2007 Consultant, North Shore University Hospital, Glen Cove, NY

    1995-1999 Assistant Attending, Bridgeport Hospital, Bridgeport, CT

    1995-1999 Assistant Attending, St. Vincent's Medical Center, Bridgeport, CT

    1995-1999 Consultant, Milford Hospital, Milford, CT

    1995-1999 Courtesy Staff, Norwalk Hospital, Norwalk, CT

    1992-1993 Assistant Attending, Beth Israel Medical Center, New York, NY

  • Research Grant

    Principal Investigator:

    2013-2018 WDI Diabetes Research Registry (Approved by the Institutional Review Board of Western University of Health Sciences; Protocol #13/ IRB/017)

    2008-2012 PEGylated liposomal encapsulation of vancomycin for MRSA pneumonia

  • Awards

    2012 Outstanding Faculty Award for Outstanding Cross Campus Colleague

    2008 American Osteopathic Association Mentor Hall of Fame Award

    1988 Wilbur P. Lutz, DO, Memorial Internal Medicine/Physical Diagnosis Award, Philadelphia College of Osteopathic Medicine

  • Organizations

    American College of Physicians (Fellow)

  • Committees

    2020- Admissions Committee, WesternU College of Osteopathic Medicine of the Pacific

    2017-2018 Diabetes Working Group, International Consortium for Health Outcomes Measurement (ICHOM)

    2011 Faculty Practice Plan Task Force, WesternU 2011 Preliminary Exam Review, COMLEX Level 1, National Board of Osteopathic Medical Examiners

    2010 Standard Setting, COMLEX Level 1, National Board of Osteopathic Medical Examiners

    2009-2012 Governor's Council, American College of Physicians Southern California Region II

    2009 Chair, Ad Hoc Working Group for Development of MPH Joint-Degree Program WesternU and Claremont Graduate University

    2007-2012Curriculum, WesternU College of Osteopathic Medicine of the Pacific

    2007 Task Force on Guidelines for Community-Acquired Pneumonia, North Shore-LIJ Health System

  • Publications

    Desai R, Khobaragade B, McCracken G, Wassall R, Taylor JJ, Bissett, SM, Pumerantz AS, Preshaw PM. Impact of diabetes and periodontal status on life quality. BDJ Open 2021; 7(9). https://doi.org/10.1038/s41405-021-00061-w

    NanoJ, Carinci F, Okunade O, Whittaker S,Walbaum M, Barnard-Kelly K, Barthelmes D, BensonT, Calderon-Margalit R, Dennaoui J, Fraser S, Haig R, Hernández-Jimenéz S, Levitt N, Mbanya JC, Naqvi S, Peters AL, Peyrot M, Prabhaharan M, Pumerantz A, RaposoJ, Santana M, Schmitt A,SkovlundSE, Ulloa ACG, Wee H-L, Zaletel J, Massi-Benedetti M;onbehalfofthe Diabetes Working Group of the International Consortium for Health OutcomesMeasurement (ICHOM). A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabet Med 2020; published online 2 March2020, doi: 10.1111/DME.14286.

    Wan SH, Pumerantz AS, Dong F, Ochoa C, Chen HH. Comparing the Influence of 2009 versus 2016 ASE/EACVI Diastolic Function Guidelines on the Prevalence and Echocardiographic Characteristics of Preclinical Diastolic Dysfunction (Stage B Heart Failure) in a Hispanic Population with Type 2 Diabetes Mellitus. J Diabetes Complications 2019; 33: 579-584.

    Pumerantz AS, Bissett SM, Dong F, Ochoa C, Wassall RR, Davila H, Barbee, Nguyen J, Vila P, Preshaw PM. Standardized Screening for Periodontitis as an Integral Part of Multidisciplinary Management of Adults with Type 2 Diabetes: An Observational Cross-Sectional Study of Cohorts in the USA and UK. BMJ Open Diab Res Care 2017; 5(1): e000413. doi: 10.1136/bmjdrc-2017-000413

    Pham C, Pumerantz AS. Integrated Practice Unit (IPU) Model at Western Diabetes Institute. California Pharmacist 2015; 62 (3): 32-37.

    Bissett, SM, Pumerantz AS, Preshaw PM. Periodontal Disease and Diabetes. J Diabetes Nurs 2015; 19(4): 134-40.

    Muppidi K, Pumerantz AS, Betageri G, Wang J. Development and Validation of a Rapid High-Performance Liquid Chromatography Method with UV Detection for the Determination of Vancomycin in Mouse Plasma. J Chromat Separation Techniq 2013; 4: 165.

    Pumerantz AS. PEGylated Liposomal Vancomycin: A Glimmer of Hope for Improving Treatment Outcomes in MRSA Pneumonia. Recent Pat Antiinfect Drug Discov 2012; Vol. 7, No. 3: 205-212.

    Muppidi K, Pumerantz AS, Wang J, Betageri G. Development and Stability Studies of Novel Liposomal Vancomycin Formulations. ISRN Pharmaceutics 2012; Volume 2012, Article ID 636743, 8 pages. doi:10.5402/2012/636743

    Muppidi K, Wang J, Betageri G, Pumerantz AS. PEGylated Liposome Encapsulation Increases the Lung Tissue Concentration of Vancomycin. Antimicrob Agents Chemother 2011; 55(10): 4537-4542.

    Pumerantz A, Muppidi K, Agnihotri S, Guerra C, Venketaraman V, Wang J, Betageri G. Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2011; 37: 140-144.

    Selwyn PA, Pumerantz AS, Durante A, Alcabes PG, Gourevitch MN, Boiselle PM, Elmore JG. Clinical Predictors of Pneumocystis carinii pneumonia, bacterial pneumonia and tuberculosis in HIV-infected patients. AIDS 1998; 12: 885-893.

    Boiselle PM, Tocino I, Hooley RJ, Pumerantz AS, Selwyn PA, Nekiesa VP, Lange RC. Chest radiograph interpretation of Pneumocystis carinii pneumonia, bacterial pneumonia, and pulmonary tuberculosis in HIV-positive patients: accuracy, distinguishing features, and mimics. J Thoracic Imaging 1997; 1: 47-53.